Thomas Fekete, MD, MACP, Thomas Durant Chair and Professor of Medicine and Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University, offered insight to WHYY about Merck’s new drug molnupiravir, which could be the first pill to treat COVID-19. Merck has asked the U.S. Food and Drug Administration to authorize the treatment.
Coronavirus (COVID-19) - Latest Information for Patients and Visitors
(La más reciente información para pacientes y visitantes)
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH